SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-034184
Filing Date
2011-06-13
Accepted
2011-06-13 10:58:55
Documents
1
Period of Report
2011-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3976
  Complete submission text file 0001209191-11-034184.txt   5657
Mailing Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011 4253681050
SCOLR Pharma, Inc. (Issuer) CIK: 0000934936 (see all company filings)

IRS No.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address SCOLR PHARMA INC. 19204 NORTH CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address
Arnett Marylou W (Reporting) CIK: 0001493392 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31982 | Film No.: 11907451